Navigation and service

Alzheimer’s Diagnostics and More: New Spin-Off "attyloid"

Spin-Off Focuses on Protein Aggregates

Jülich/Düsseldorf, 7 March 2018 – A new company named “attyloid GmbH” was founded as a spin-off by Forschungszentrum Jülich and Heinrich Heine University Düsseldorf (HHU) a few days ago. The researchers involved have developed a method of measuring tiny protein aggregates with unprecedented sensitivity. The technology, called “sFIDA”, can be used for the early detection of neurodegenerative diseases such as Alzheimer’s, for example. It is also suitable for the quality control of biopharmaceuticals such as enzymes and antibodies. The development of the sFIDA technology was funded by the German Federal Ministry of Education and Research through the VIP programme. For the spin-off, the researchers received financial support from the Helmholtz Enterprise initiative and are currently also funded by the North Rhine-Westphalian START-UP programme, which supports universities in founding spin-offs.

More (in German)







Dear visitor,

To make our website suit your needs even more and to give it a more appealing design, we would like you to answer a few short questions.

Answering these questions will take approx. 10 min.

Start now Close window

Thank you for your support!


In case you have already taken part in our survey or in case you have no time to take part now, you can simply close the window by clicking "close".

If you have any questions on the survey, please do not hesitate to contact:


Your Team at Forschungszentrum Jülich


Note: Forschungszentrum Jülich works with the market research institute SKOPOS to anonymously conduct and analyze the survey. SKOPOS complies with the statutory requirements on data protection as well as with the regulations of ADM (Arbeitskreis Deutscher Markt- und Sozialforschungsinstitute e.V.) and ESOMAR (Europäische Gesellschaft für Meinungs- und Marketingforschung). Your data will not be forwarded to third parties.